Expression of ROR1 in patients with renal cancer--a potential diagnostic marker
- PMID: 21079657
- PMCID: PMC3904057
Expression of ROR1 in patients with renal cancer--a potential diagnostic marker
Abstract
Background: The ectopic expression of receptor tyrosine kinase Ror1 has been reported in patients with hematological malignancies such as chronic lymphocytic leukemia and acute lymphoblastic leukemia. Here we report, for the first time, expression of ROR1 gene in both tumor tissues and peripheral blood mononuclear cells (PBMC) from patients with renal cancer (RC).
Methods: In the current study, the expression of ROR1 gene was semi-quantitatively measured in PBMC and tumor tissues from 16 RC patients as well as PBMC from 22 healthy individuals relative to the expression of the housekeeping gene phosphoglucomutase 1 by RT-PCR.
Results: Our results showed that ROR1 was expressed at gene level in 81.3 percent of renal tumor tissues (13 out of 16) whereas it was expressed in 94 percent of PBMC from RC patients (15 out of 16). A weak expression of ROR1 was observed in PBMC of 4 out of 22 healthy individual. A significant expression of ROR1 was observed in PBMC from RC patients when compared to that in PBMC from normal healthy individuals (P less than 0.001). The expression of ROR1 in PBMC may reflect a shedding of tumor cells into blood stream.
Conclusion: We conclude that detection of a high level of ROR1 expression in blood cells might assist in early detection of renal malignancies, providing taking into consideration the clinical symptoms of the disease.
Keywords: ROR1; Ectopic expression; Renal cancer.
Figures
References
-
- Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Vasko J, Ljungberg B. The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma. Clin Cancer Res. 2005;11:1129–1135. - PubMed
-
- Linehan W M, Walther M M, Zbar B. The genetic basis of cancer of the kidney. J Urol . 2003;170:2163–2172. - PubMed
-
- Pastorek J, Pastorekova S, Callebaut I, Mornon J P, Zelnik V, Opavsky R, Zatovicova M, Liao S, Portetelle D, Stanbridge E J, Zavada J, Burny A, Kettmann R. Cloning and characterization of MN a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene. 1994;9:2877–2888. - PubMed
-
- Shabani M, Asgarian-Omran H, Vossough P, Ramazan A, Sharifian R A, Faranoush M, Ghragozlou S, Khoshnoodi J, Roohi A, Jeddi-Tehrani M, Mellstedt H, Rabbani H, Shokri F. Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms' tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia. Leuk Lymphoma. 2008;49:1360–1367. - PubMed
-
- Fukuda T, Chen L, Endo T, Tang L, Lu D, Castro J E, Widhopf G F, Rassenti L Z, Cantwell M J, Prussak C E, Dennis A, Carson D A, Kipps T J. Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc Natl Acad Sci USA. 2008;105(8):3047–3052. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous